Eli Lilly and Regeneron are among the first seven companies the FDA has selected for its PreCheck Pilot Program, CNBC has ...

The US may open a trade investigation into Switzerland's pharmaceutical industry, threatening tariffs on $35.5 billion in ...

Transaction Valued at $122.5M Establishes 20,000-Liter US Biologics Drug Substance Manufacturing Platform, Covering ...

Forward-thinking manufacturers build native compliance protocols as a workflow, not as an afterthought—a pitfall that many ...

The U.S. Food and Drug Administration on Monday selected Eli Lilly , Regeneron and five ​other companies for a pilot program ...

However, the rapid rise of automation, fintech integration, and data-driven manufacturing is transforming pharma production ...

Residues of pharmaceutical products can enter the environment during the manufacturing process, during usage, and disposal. With the growing trend in sustainable practices, the translation of ...

After a site visit by FDA inspectors yielded a Form 483 for Genzyme Ireland in early 2026, the Sanofi subsidiary is facing further reprimand from the U.S. regulator.  | After a site visit by FDA ...

Linuo Pharmaceutical Packaging Co., Ltd. (Linuo Pharmaceutical Packaging) was invited to speak at the Third Global Expansion ...

Andreas Eschbach is the founder and CEO of eschbach, a software company that helps production teams work smarter and enhance collaboration. The pharmaceutical industry stands at a critical juncture.

Pharmaceutical companies are on an M&A spree that could break records this year as they look for novel drug and clinical-stage candidates to bolster the development pipeline.

Food and Drug Administration has ‌selected Eli Lilly and Regeneron ‌among seven companies for a pilot ​program to accelerate ...